Table 3.
Median | Interquartile Range | |
---|---|---|
| ||
All Prescribers: | ||
Young Children | 2 | 1–4 |
Adults | 7 | 6–8 |
| ||
Child/Adolescent Psychiatrists: | ||
Young Children | 3 | 2–4 |
Adults | 6 | 4–7 |
| ||
Family Medicine Physicians: | ||
Young Children | 1 | 1-1 |
Adults | 5 | 4–6 |
| ||
Other Psychiatrists: | ||
Young Children | 2 | 1–3 |
Adults | 7 | 6–8 |
| ||
First Quartile of Total Antipsychotic Volume | ||
Young Children | 2 | 1–3 |
Adults | 5 | 4–7 |
| ||
Second Quartile of Total Antipsychotic Volume | ||
Young Children | 2 | 1–3 |
Adults | 6 | 5–7 |
| ||
Third Quartile of Total Antipsychotic Volume | ||
Young Children | 3 | 1–4 |
Adults | 7 | 6–8 |
| ||
Fourth Quartile of Total Antipsychotic Volume | ||
Young Children | 3 | 1–4 |
Adults | 8 | 7–9 |
Source: Xponent™ database, 1/08 – 12/11, IMS Health Incorporated. All Rights Reserved.
Notes: Analyses use IMS Health's Xponent™ linked with American Medical Association Masterfile data. Note: All FGAs are viewed as being a single ingredient due to the very low share of first-generation antipsychotics used among children 0–9.